21 CFR Part 868 · Anesthesiology Devices

21 CFR 868.5470

Hyperbaric chamber

21 CFR 868.5470 is the regulation titled “Hyperbaric chamber” in 21 CFR Part 868, Anesthesiology Devices. Since 2021, 1 FDA warning letter has cited it.

Letters citing it
1 since 2021
Jan 1 to Oct 30, 2026
0 against 0 on the same dates in 2025
Most often cited with
21 CFR 801.20, in 1 letter
Closed out
0% of these letters have a published close-out
See the letter citing 21 CFR 868.5470 →

Letters citing it, by year issued

It is a medical device letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 02022
  3. 12023
  4. 02024
  5. 02025
  6. 02026

The regulation

Read the text of 21 CFR 868.5470 (eCFR, as of Sep 1, 2026)

(a) Identification. A hyperbaric chamber is a device that is intended to increase the environmental oxygen pressure to promote the movement of oxygen from the environment to a patient's tissue by means of pressurization that is greater than atmospheric pressure. This device does not include topical oxygen chambers for extremities (§ 878.5650).

(b) Classification. Class II (performance standards).

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 868.5470.

Latest letters citing it

The letter citing 21 CFR 868.5470 that FDA posted most recently.

See the letter citing 21 CFR 868.5470 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.